About Us - Selvita

Key facts
Management
Our history
Site locations

Key facts
Management
Our history
Site locations

About Us

Abstract macro photograph of oil and water bubbles in blue light.

Empowering to deliver life-saving therapies

Selvita is a leading European CRO supporting pharma and biotech companies with flexible, science-driven R&D services. We offer integrated or standalone solutions in drug discovery, preclinical studies, and GMP/GLP-compliant analytical development. With strong expertise across early to late development stages, we help accelerate new therapies by delivering high-quality data that enables smart decisions and faster time to market.

GET TO KNOW US

Key facts

1
Located in the heart of Europe, with over 950 employees across state -of-the-art labs in Poland and Croatia, and strategic offices in the U.K. and the U.S.
2
Expanding the value proposition through organic growth and strategic acquisitions, with a focus on long-term development.
3
Providing integrated solutions for drug discovery, with expertise in medicinal chemistry, biology, and DMPK, supporting projects from target validation to clinical development.
4
Operating under GMP/GLP standards, with a focus on drug development, with regulatory-driven testing for small molecules and biologics.
5
A public company, listed on the Warsaw Stock Exchange (WSE:SLV)

LEADERSHIP MATTERS

Leadership Team

By upholding the highest standards of corporate governance, our team fosters trust and accountability among stakeholders, driving the company’s sustainable growth.

Management Board Supervisiory Board

How we got started

Our History

Selvita was founded in Kraków, Poland, in the Summer of 2007, starting as a hybrid: CRO – drug discovery mix of a company.

2007

In late 2008 we acquired BioCentrum, a Jagiellonian University spin-off biology CRO, specializing in biochemistry, enzymes and protein production.

2008

In December 2014, we have successfully completed our Initial Public Offering (IPO) and entered the main market of the Warsaw Stock Exchange (WSE), raising PLN 27.3 million.

2014

In 2015, we have established our first U.S. subsidiary and an office in Boston, MA. Same year we also launched our U.K. subsidiary in Cambridge, UK.

2015

In September, 2015, we have expanded our activity into bioinformatics and personalized medicine, with the launch of a new company: Ardigen.

2015

In March 2016, we have officially opened our second U.S. location in San Francisco, CA.

2016

In May 2017 we opened our Poznan site, adding more contract chemistry laboratories to our portfolio of research infrastructure.

2016

October 2019 marks one of the most important corporate milestones in our history: corporate split into two independent entities Selvita and Ryvu Therapeutics.

Selvita continuous as a contract research organization, while Ryvu Therapeutics focuses on proprietary oncology drug discovery and development.

2019

In June 2020, we have successfully conducted a secondary public offering (SPO), raising EUR 20.6 million from investors with an aim to fund acquisitions and further organic growth.

It was the second largest transaction in terms of capital raised, on the Warsaw Stock Exchange that year.

2020

In January 2021 Selvita has acquired Fidelta, a CRO located in Croatia, from Galapagos.

Acquisition of Fidelta substantially expanded Selvita’s integrated drug discovery services offering and almost doubled Selvita’s revenues.

2021

In March 2023, we have completed the construction of our new headquarters – Hexagon – in Krakow, Poland. Adding almost 4,000 m² of the new laboratory space and significantly scaling our operations.

2023

In the Spring of 2024, we made an acquisition of PozLab as well as opened a new research site in Wrocław. These strategic decisions have expanded our portfolio of services with the formulation and drug development capabilities, as well as antibody drug discovery expertise.

2024

Lorem ipsum

Research Site Locations

Selvita Kraków

Our two research sites in Krakow include our headquarters as well as, provide drug discovery and drug development and contract testing services.

What Drives Us

Values

Two women in lab coats collaborating while examining data on a computer screen.

Partnership

Partnership: We work hand in hand, not only with our partners but also with each other, to provide a seamless, cooperative experience that is focused on the same goal. Collaboration is crucial to build trust and achieve exceptional results.

Excellence

Excellence: We have a drive for continuous development, openness to gather feedback, and willingness to propose optimal solutions. Our expertise is at the forefront of the quality of the services we provide. Delivering successful scientific solutions to our partners inspires us to grow.

Passion

We have a passion for science and learning. It’s what gives us the energy to aim for more every day and contribute to the development of new therapies for patients. We enjoy our work and are proud to share our knowledge and experience.

Commitment

We pride ourselves on trustworthy, credible solutions for high-quality services. We have a responsibility to approach each project we undertake honestly, to deliver reliable results that are true to our word.

Integrity

We know that our people are the biggest asset we have. We appreciate and respect their commitment, contribution, and their personal values. We approach every stakeholder with respect, kindness, and consideration

GOOD PRACTISES

Social Responsibility

Two women in lab coats collaborating on a computer in a laboratory setting.

GxP Labs compliance

Provision of highest quality standards of pharmaceutical services under GMP and GLP regulations.

Employee well-being

Our company fosters a supportive and inclusive workplace, emphasizing employee development, diversity and inclusion.

Group of scientists collaborating in a laboratory, conducting experiments and analyzing data.

Overview

Investors & Media

Selvita (WSE:SLV) is a publicly traded company committed to becoming a leading global contract research and development organization. We drive growth through strategic combination of organic expansion and acquisitions, delivering research solutions to our partners worldwide.

Go to Investors & Media page

JOIN OUR TEAM

Careers at Selvita

Be a part of our mission to develop groundbreaking therapies and transform patient care. Explore exciting career opportunities with us and help shape the future of medicine.

Open positions

Shortcuts